Zhejiang Medicine Co Ltd (600216) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.062x

Based on the latest financial reports, Zhejiang Medicine Co Ltd (600216) has a cash flow conversion efficiency ratio of 0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥690.77 Million ≈ $101.08 Million USD) by net assets (CN¥11.21 Billion ≈ $1.64 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhejiang Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Zhejiang Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Zhejiang Medicine Co Ltd carry for a breakdown of total debt and financial obligations.

Zhejiang Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Medicine Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
BRP Inc
TO:DOO
0.627x
Zhejiang Yonghe Refrigerant Co Ltd
SHG:605020
0.030x
Shenzhen Rongda Photosensitive & Technology Co Ltd
SHE:300576
0.035x
Ceconomy AG
XETRA:CEC
2.309x
Visual Photonics Epitaxy Co Ltd
TW:2455
0.080x
Spartan Resources Ltd
AU:SPR
-0.015x
Staidson Beijing Biopharma
SHE:300204
-0.046x
Hunan Boyun New Materials Co Ltd
SHE:002297
0.037x

Annual Cash Flow Conversion Efficiency for Zhejiang Medicine Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Medicine Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Medicine Co Ltd (600216) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥10.87 Billion
≈ $1.59 Billion
CN¥1.22 Billion
≈ $179.01 Million
0.113x +77.21%
2023-12-31 CN¥9.99 Billion
≈ $1.46 Billion
CN¥634.31 Million
≈ $92.82 Million
0.064x +18.47%
2022-12-31 CN¥9.71 Billion
≈ $1.42 Billion
CN¥520.60 Million
≈ $76.18 Million
0.054x -56.69%
2021-12-31 CN¥9.18 Billion
≈ $1.34 Billion
CN¥1.14 Billion
≈ $166.33 Million
0.124x -20.90%
2020-12-31 CN¥8.03 Billion
≈ $1.18 Billion
CN¥1.26 Billion
≈ $183.90 Million
0.157x +188.76%
2019-12-31 CN¥8.25 Billion
≈ $1.21 Billion
CN¥447.25 Million
≈ $65.45 Million
0.054x -24.45%
2018-12-31 CN¥8.08 Billion
≈ $1.18 Billion
CN¥579.91 Million
≈ $84.86 Million
0.072x +10.84%
2017-12-31 CN¥7.78 Billion
≈ $1.14 Billion
CN¥503.47 Million
≈ $73.67 Million
0.065x +34.62%
2016-12-31 CN¥6.99 Billion
≈ $1.02 Billion
CN¥336.14 Million
≈ $49.19 Million
0.048x +198.51%
2015-12-31 CN¥6.62 Billion
≈ $968.00 Million
CN¥106.54 Million
≈ $15.59 Million
0.016x -80.78%
2014-12-31 CN¥6.56 Billion
≈ $960.18 Million
CN¥549.90 Million
≈ $80.47 Million
0.084x -17.10%
2013-12-31 CN¥6.48 Billion
≈ $948.29 Million
CN¥655.09 Million
≈ $95.86 Million
0.101x -22.42%
2012-12-31 CN¥6.20 Billion
≈ $906.81 Million
CN¥807.49 Million
≈ $118.16 Million
0.130x -37.18%
2011-12-31 CN¥4.40 Billion
≈ $643.92 Million
CN¥912.75 Million
≈ $133.56 Million
0.207x -39.12%
2010-12-31 CN¥3.86 Billion
≈ $565.33 Million
CN¥1.32 Billion
≈ $192.62 Million
0.341x -33.46%
2009-12-31 CN¥2.86 Billion
≈ $418.70 Million
CN¥1.47 Billion
≈ $214.39 Million
0.512x -22.67%
2008-12-31 CN¥1.81 Billion
≈ $265.19 Million
CN¥1.20 Billion
≈ $175.59 Million
0.662x +154.11%
2007-12-31 CN¥873.73 Million
≈ $127.85 Million
CN¥227.67 Million
≈ $33.32 Million
0.261x +19.49%
2006-12-31 CN¥777.31 Million
≈ $113.74 Million
CN¥169.51 Million
≈ $24.80 Million
0.218x +535.06%
2005-12-31 CN¥732.23 Million
≈ $107.15 Million
CN¥25.14 Million
≈ $3.68 Million
0.034x -79.39%
2004-12-31 CN¥645.68 Million
≈ $94.48 Million
CN¥107.60 Million
≈ $15.75 Million
0.167x +58.20%
2003-12-31 CN¥628.48 Million
≈ $91.97 Million
CN¥66.20 Million
≈ $9.69 Million
0.105x +186.82%
2002-12-31 CN¥629.71 Million
≈ $92.15 Million
CN¥23.13 Million
≈ $3.38 Million
0.037x -77.25%
2001-12-31 CN¥608.50 Million
≈ $89.04 Million
CN¥98.25 Million
≈ $14.38 Million
0.161x +868.83%
2000-12-31 CN¥635.03 Million
≈ $92.92 Million
CN¥10.58 Million
≈ $1.55 Million
0.017x +120.07%
1999-12-31 CN¥625.07 Million
≈ $91.47 Million
CN¥-51.90 Million
≈ $-7.60 Million
-0.083x -150.15%
1998-12-31 CN¥348.61 Million
≈ $51.01 Million
CN¥57.72 Million
≈ $8.45 Million
0.166x --

About Zhejiang Medicine Co Ltd

SHG:600216 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.02 Billion
CN¥13.78 Billion CNY
Market Cap Rank
#6276 Global
#1392 in China
Share Price
CN¥14.33
Change (1 day)
-1.44%
52-Week Range
CN¥13.33 - CN¥18.38
All Time High
CN¥20.16
About

Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and medical products in China and internationally. The company offers synthetic vitamin E, natural vitamin E, ß-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also provides fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition produ… Read more